Global Factor VIII Deficiency Treatment Market 2017-2021

About Factor VIII

Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endothelial cells outside the liver across the body. This protein mixes in the bloodstream in an inactive form, and binds to another molecule called von Willebrand factor, until a damage to blood vessels occur. In response to injury, coagulation factor VIII gets activated and separates from von Willebrand factor.

Technavio’s analysts forecast the global factor VIII market to grow at a CAGR of 5.59% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global factor VIII market for 2017-2021. To calculate the market size, the report considers the global demand for factor VIII.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Factor VIII Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Bayer HealthCare
• CSL
• Grifols
• Novo Nordisk
• Pfizer
• Shire

Other prominent vendors
• Alnylam Pharmaceuticals
• Amarna Therapeutics
• Asklepios BioPharmaceutical
• Biogen Idec
• BioMarin Pharmaceutical
• Catalyst Biosciences
• Chiesi Pharmaceutical
• Dimension Therapeutics
• Emergent BioSolutions
• F. Hoffmann-La Roche
• Kedrion
• Octapharma
• rEVO Biologics
• OPKO Biologics
• Sangamo Therapeutics
• Spark Therapeutics
• Swedish Orphan Biovitrum
• uniQure

Market driver
• Paradigm shift towards the development of drugs with extended half-life
• For a full, detailed list, view our report

Market challenge
• Low diagnosis rate affecting the market growth
• For a full, detailed list, view our report

Market trend
• Increasing investments of vendors to improve the production expertise
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.